Illinois Compiled Statutes
Information maintained by the Legislative
Updating the database of the Illinois Compiled Statutes (ILCS) is an ongoing process.
Recent laws may not yet be included in the ILCS database, but they are found on this site as Public
soon after they become law. For information concerning the relationship between statutes and Public Acts, refer to the
Because the statute database is maintained primarily for legislative drafting purposes,
statutory changes are sometimes included in the statute database before they take effect.
If the source note at the end of a Section of the statutes includes a Public Act that has
not yet taken effect, the version of the law that is currently in effect may have already
been removed from the database and you should refer to that Public Act to see the changes
made to the current law.
225 ILCS 85/3
(225 ILCS 85/3)
(Section scheduled to be repealed on January 1, 2018)
For the purpose of this Act, except where otherwise
(a) "Pharmacy" or "drugstore" means and includes every store, shop,
pharmacy department, or other place where pharmacist
by a pharmacist (1) where drugs, medicines, or poisons are
dispensed, sold or
offered for sale at retail, or displayed for sale at retail; or
prescriptions of physicians, dentists, advanced practice nurses, physician assistants, veterinarians, podiatric physicians, or
optometrists, within the limits of their
compounded, filled, or dispensed; or (3) which has upon it or
it, or affixed to or used in connection with it, a sign bearing the word or
words "Pharmacist", "Druggist", "Pharmacy", "Pharmaceutical
Care", "Apothecary", "Drugstore",
"Medicine Store", "Prescriptions", "Drugs", "Dispensary", "Medicines", or any word
or words of similar or like import, either in the English language
or any other language; or (4) where the characteristic prescription
sign (Rx) or similar design is exhibited; or (5) any store, or
or other place with respect to which any of the above words, objects,
signs or designs are used in any advertisement.
(b) "Drugs" means and includes (l) articles recognized
in the official United States Pharmacopoeia/National Formulary (USP/NF),
or any supplement thereto and being intended for and having for their
main use the diagnosis, cure, mitigation, treatment or prevention of
disease in man or other animals, as approved by the United States Food and
Drug Administration, but does not include devices or their components, parts,
or accessories; and (2) all other articles intended
for and having for their main use the diagnosis, cure, mitigation,
treatment or prevention of disease in man or other animals, as approved
by the United States Food and Drug Administration, but does not include
devices or their components, parts, or accessories; and (3) articles
(other than food) having for their main use and intended
to affect the structure or any function of the body of man or other
animals; and (4) articles having for their main use and intended
for use as a component or any articles specified in clause (l), (2)
or (3); but does not include devices or their components, parts or
(c) "Medicines" means and includes all drugs intended for
human or veterinary use approved by the United States Food and Drug
(d) "Practice of pharmacy" means (1) the interpretation and the provision of assistance in the monitoring, evaluation, and implementation of prescription drug orders; (2) the dispensing of prescription drug orders; (3) participation in drug and device selection; (4) drug administration limited to the administration of oral, topical, injectable, and inhalation as follows: in the context of patient education on the proper use or delivery of medications; vaccination of patients 14 years of age and older pursuant to a valid prescription or standing order, by a physician licensed to practice medicine in all its branches, upon completion of appropriate training, including how to address contraindications and adverse reactions set forth by rule, with notification to the patient's physician and appropriate record retention, or pursuant to hospital pharmacy and therapeutics committee policies and procedures; (5) vaccination of patients ages 10 through 13 limited to the Influenza (inactivated influenza vaccine and live attenuated influenza intranasal vaccine) and Tdap (defined as tetanus, diphtheria, acellular pertussis) vaccines, pursuant to a valid prescription or standing order, by a physician licensed to practice medicine in all its branches, upon completion of appropriate training, including how to address contraindications and adverse reactions set forth by rule, with notification to the patient's physician and appropriate record retention, or pursuant to hospital pharmacy and therapeutics committee policies and procedures; (6) drug regimen review; (7) drug or drug-related research; (8) the provision of patient counseling; (9) the practice of telepharmacy; (10) the provision of those acts or services necessary to provide pharmacist care; (11) medication therapy management; and (12) the responsibility for compounding and labeling of drugs and devices (except labeling by a manufacturer, repackager, or distributor of non-prescription drugs and commercially packaged legend drugs and devices), proper and safe storage of drugs and devices, and maintenance of required records. A pharmacist who performs any of the acts defined as the practice of pharmacy in this State must be actively licensed as a pharmacist under this Act.
(e) "Prescription" means and includes any written, oral, facsimile, or
electronically transmitted order for drugs
or medical devices, issued by a physician licensed to practice medicine in
all its branches, dentist, veterinarian, podiatric physician, or
optometrist, within the
limits of their licenses, by a physician assistant in accordance with
subsection (f) of Section 4, or by an advanced practice nurse in
accordance with subsection (g) of Section 4, containing the
following: (l) name
of the patient; (2) date when prescription was issued; (3) name
and strength of drug or description of the medical device prescribed;
and (4) quantity; (5) directions for use; (6) prescriber's name,
and signature; and (7) DEA number where required, for controlled
The prescription may, but is not required to, list the illness, disease, or condition for which the drug or device is being prescribed. DEA numbers shall not be required on inpatient drug orders.
(f) "Person" means and includes a natural person, copartnership,
association, corporation, government entity, or any other legal
(g) "Department" means the Department of Financial and
(h) "Board of Pharmacy" or "Board" means the State Board
of Pharmacy of the Department of Financial and Professional Regulation.
means the Secretary
of Financial and Professional Regulation.
(j) "Drug product selection" means the interchange for a
prescribed pharmaceutical product in accordance with Section 25 of
this Act and Section 3.14 of the Illinois Food, Drug and Cosmetic Act.
(k) "Inpatient drug order" means an order issued by an authorized
prescriber for a resident or patient of a facility licensed under the
Nursing Home Care Act, the ID/DD Community Care Act, the Specialized Mental Health Rehabilitation Act of 2013, or the Hospital Licensing Act, or "An Act in relation to
the founding and operation of the University of Illinois Hospital and the
conduct of University of Illinois health care programs", approved July 3, 1931,
as amended, or a facility which is operated by the Department of Human
Services (as successor to the Department of Mental Health
and Developmental Disabilities) or the Department of Corrections.
(k-5) "Pharmacist" means an individual health care professional and
provider currently licensed by this State to engage in the practice of
(l) "Pharmacist in charge" means the licensed pharmacist whose name appears
on a pharmacy license and who is responsible for all aspects of the
operation related to the practice of pharmacy.
(m) "Dispense" or "dispensing" means the interpretation, evaluation, and implementation of a prescription drug order, including the preparation and delivery of a drug or device to a patient or patient's agent in a suitable container appropriately labeled for subsequent administration to or use by a patient in accordance with applicable State and federal laws and regulations.
"Dispense" or "dispensing" does not mean the physical delivery to a patient or a
patient's representative in a home or institution by a designee of a pharmacist
or by common carrier. "Dispense" or "dispensing" also does not mean the physical delivery
of a drug or medical device to a patient or patient's representative by a
pharmacist's designee within a pharmacy or drugstore while the pharmacist is
on duty and the pharmacy is open.
(n) "Nonresident pharmacy"
means a pharmacy that is located in a state, commonwealth, or territory
of the United States, other than Illinois, that delivers, dispenses, or
distributes, through the United States Postal Service, commercially acceptable parcel delivery service, or other common
carrier, to Illinois residents, any substance which requires a prescription.
(o) "Compounding" means the preparation and mixing of components, excluding flavorings, (1) as the result of a prescriber's prescription drug order or initiative based on the prescriber-patient-pharmacist relationship in the course of professional practice or (2) for the purpose of, or incident to, research, teaching, or chemical analysis and not for sale or dispensing. "Compounding" includes the preparation of drugs or devices in anticipation of receiving prescription drug orders based on routine, regularly observed dispensing patterns. Commercially available products may be compounded for dispensing to individual patients only if all of the following conditions are met: (i) the commercial product is not reasonably available from normal distribution channels in a timely manner to meet the patient's needs and (ii) the prescribing practitioner has requested that the drug be compounded.
(r) "Patient counseling" means the communication between a pharmacist or a student pharmacist under the supervision of a pharmacist and a patient or the patient's representative about the patient's medication or device for the purpose of optimizing proper use of prescription medications or devices. "Patient counseling" may include without limitation (1) obtaining a medication history; (2) acquiring a patient's allergies and health conditions; (3) facilitation of the patient's understanding of the intended use of the medication; (4) proper directions for use; (5) significant potential adverse events; (6) potential food-drug interactions; and (7) the need to be compliant with the medication therapy. A pharmacy technician may only participate in the following aspects of patient counseling under the supervision of a pharmacist: (1) obtaining medication history; (2) providing the offer for counseling by a pharmacist or student pharmacist; and (3) acquiring a patient's allergies and health conditions.
(s) "Patient profiles" or "patient drug therapy record" means the
obtaining, recording, and maintenance of patient prescription
information, including prescriptions for controlled substances, and
(u) "Medical device" means an instrument, apparatus, implement, machine,
contrivance, implant, in vitro reagent, or other similar or related article,
including any component part or accessory, required under federal law to
bear the label "Caution: Federal law requires dispensing by or on the order
of a physician". A seller of goods and services who, only for the purpose of
retail sales, compounds, sells, rents, or leases medical devices shall not,
by reasons thereof, be required to be a licensed pharmacy.
(v) "Unique identifier" means an electronic signature, handwritten
signature or initials, thumb print, or other acceptable biometric
or electronic identification process as approved by the Department.
(w) "Current usual and customary retail price" means the price that a pharmacy charges to a non-third-party payor.
(x) "Automated pharmacy system" means a mechanical system located within the confines of the pharmacy or remote location that performs operations or activities, other than compounding or administration, relative to storage, packaging, dispensing, or distribution of medication, and which collects, controls, and maintains all transaction information.
(y) "Drug regimen review" means and includes the evaluation of prescription drug orders and patient records for (1)
known allergies; (2) drug or potential therapy contraindications;
(3) reasonable dose, duration of use, and route of administration, taking into consideration factors such as age, gender, and contraindications; (4) reasonable directions for use; (5) potential or actual adverse drug reactions; (6) drug-drug interactions; (7) drug-food interactions; (8) drug-disease contraindications; (9) therapeutic duplication; (10) patient laboratory values when authorized and available; (11) proper utilization (including over or under utilization) and optimum therapeutic outcomes; and (12) abuse and misuse.
(z) "Electronic transmission prescription" means any prescription order for which a facsimile or electronic image of the order is electronically transmitted from a licensed prescriber to a pharmacy. "Electronic transmission prescription" includes both data and image prescriptions.
(aa) "Medication therapy management services" means a distinct service or group of services offered by licensed pharmacists, physicians licensed to practice medicine in all its branches, advanced practice nurses authorized in a written agreement with a physician licensed to practice medicine in all its branches, or physician assistants authorized in guidelines by a supervising physician that optimize therapeutic outcomes for individual patients through improved medication use. In a retail or other non-hospital pharmacy, medication therapy management services shall consist of the evaluation of prescription drug orders and patient medication records to resolve conflicts with the following:
(1) known allergies;
(2) drug or potential therapy contraindications;
(3) reasonable dose, duration of use, and route of
administration, taking into consideration factors such as age, gender, and contraindications;
(4) reasonable directions for use;
(5) potential or actual adverse drug reactions;
(6) drug-drug interactions;
(7) drug-food interactions;
(8) drug-disease contraindications;
(9) identification of therapeutic duplication;
(10) patient laboratory values when authorized and
(11) proper utilization (including over or under
utilization) and optimum therapeutic outcomes; and
(12) drug abuse and misuse.
"Medication therapy management services" includes the following:
(1) documenting the services delivered and
communicating the information provided to patients' prescribers within an appropriate time frame, not to exceed 48 hours;
(2) providing patient counseling designed to enhance
a patient's understanding and the appropriate use of his or her medications; and
(3) providing information, support services, and
resources designed to enhance a patient's adherence with his or her prescribed therapeutic regimens.
"Medication therapy management services" may also include patient care functions authorized by a physician licensed to practice medicine in all its branches for his or her identified patient or groups of patients under specified conditions or limitations in a standing order from the physician.
"Medication therapy management services" in a licensed hospital may also include the following:
(1) reviewing assessments of the patient's health
(2) following protocols of a hospital pharmacy and
therapeutics committee with respect to the fulfillment of medication orders.
(bb) "Pharmacist care" means the provision by a pharmacist of medication therapy management services, with or without the dispensing of drugs or devices, intended to achieve outcomes that improve patient health, quality of life, and comfort and enhance patient safety.
(cc) "Protected health information" means individually identifiable health information that, except as otherwise provided, is:
(1) transmitted by electronic media;
(2) maintained in any medium set forth in the
definition of "electronic media" in the federal Health Insurance Portability and Accountability Act; or
(3) transmitted or maintained in any other form or
"Protected health information" does not include individually identifiable health information found in:
(1) education records covered by the federal Family
Educational Right and Privacy Act; or
(2) employment records held by a licensee in its role
(dd) "Standing order" means a specific order for a patient or group of patients issued by a physician licensed to practice medicine in all its branches in Illinois.
(ee) "Address of record" means the address recorded by the Department in the applicant's or licensee's application file or license file, as maintained by the Department's licensure maintenance unit.
(ff) "Home pharmacy" means the location of a pharmacy's primary operations.
(Source: P.A. 97-38, eff. 6-28-11; 97-227, eff. 1-1-12; 97-813, eff. 7-13-12; 97-1043, eff. 8-21-12; 98-104, eff. 7-22-13; 98-214, eff. 8-9-13; 98-756, eff. 7-16-14.)